Blood Biomarkers for Neurodegeneration

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

198 papers

Showing 121-132 of total 198 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2023CrossrefDirectly related8 citations

Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers

Richard Novobilský; Petra Bartova; Karin Lichá; Michal Bar; David Stejskal; Pavlína Kusnierova

Dec 14, 2023Frontiers in Human Neuroscience

2023OpenAlexDirectly related25 citations

Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts

Charles Bernick; Guogen Shan; Aaron Ritter; Nicholas J. Ashton; Kaj Blennow; Juan Lantero‐Rodriguez; Anniina Snellman; Henrik Zetterberg

Oct 12, 2023Alzheimer s Research & Therapy

2023OpenAlexDirectly related9 citations

Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease

Carla R. Schubert; Adam J. Paulsen; Aaron Alex Pinto; Richard J. Chappell; Yanjun Chen; Luigi Ferrucci; Laura M. Hancock; Karen J. Cruickshanks; Natascha Merten

Sep 12, 2023Alzheimer Disease & Associated Disorders

2023OpenAlexDirectly related1 citations

Delirium, blood biomarkers for neurodegeneration, and dementia

Vincent Planche

Jul 14, 2023The Lancet Healthy Longevity

2023OpenAlexSupporting evidence1,644 citations

Role of neuroinflammation in neurodegeneration development

Weifeng Zhang; Dan Xiao; Qinwen Mao; Haibin Xia

Jul 12, 2023Signal Transduction and Targeted Therapy

2022OpenAlexDirectly related263 citations

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

Fernando González‐Ortiz; Michael Turton; Przemysław R. Kac; Denis S. Smirnov; Enrico Premi; Roberta Ghidoni; Luisa Benussi; Valentina Cantoni; Claudia Saraceno; Jasmine Rivolta; Nicholas J. Ashton; Barbara Borroni; Douglas Galasko; Peter Harrison; Henrik Zetterberg; Kaj Blennow; Thomas K. Karikari

Dec 27, 2022Brain

2022OpenAlexSupporting evidence507 citations

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

Priyanka Rawat; Ujala Sehar; Jasbir Bisht; Ashley Selman; John Culberson; P. Hemachandra Reddy

Oct 25, 2022International Journal of Molecular Sciences

2022OpenAlexDirectly related628 citations

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

Oskar Hansson; Rebecca M. Edelmayer; Adam L. Boxer; María C. Carrillo; Michelle M. Mielke; Gil D. Rabinovici; Stephen Salloway; Reisa A. Sperling; Henrik Zetterberg; Charlotte E. Teunissen

Jul 31, 2022Alzheimer s & Dementia

2021CrossrefSupporting evidence3 citations

Presence of endogenous Aβ in plasma of patient with Alzheimer’s disease differentiates Aβ oligomerization tendencies caused by synthetic Aβ

Youngki Choi; Ji Sun Yu; Yechan Joh; Sungmin Kang; Young Chul Youn; Seong Soo An; Sangyun Kim

Dec 1, 2021Alzheimer's & Dementia

2021CrossrefSupporting evidence1 citations

High precision plasma Aβ42/Aβ40 ratio detects early amyloid deposition in non‐demented elderly adults

Dai Shi; Lei Zhang; Tengfei Guo

Dec 1, 2021Alzheimer's & Dementia

2021CrossrefDirectly related206 citations

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Henrik Zetterberg; Kaj Blennow

Dec 1, 2021Molecular Neurodegeneration

2021CrossrefDirectly related0 citations

Abstract 12049: Orthostatic Hypertension is Associated With Lower Plasma aβ 42 /aβ 40 Ratio: The Multidomain Alzheimer Preventive Trial (MAPT)

Laure Rouch; Yves Rolland; Olivier Hanon; Jean-Sébastien Vidal; Sandrine Andrieu; Philipe de Souto Barreto; Bruno Vellas

Nov 16, 2021Circulation